|
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J. Biol. Chem., Vol. 282, Issue 29, 21160-21168, July 20, 2007
Nitric Oxide Is Critical for Inducing Phosphatidic Acid Accumulation in Xylanase-elicited Tomato Cells*
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ABSTRACT |
|---|
|
|
|---|
1 and PR1 mRNA levels decreased when NO or PA production were compromised. Finally, we have shown that NO and PA are involved in the induction of cell death by xylanase. Treatment with NO scavenger cPTIO, PLC inhibitor U73122
[GenBank]
, or DGK inhibitor R59022
[GenBank]
diminished xylanase-induced cell death. On the basis of biochemical and pharmacological experimental results, we have shown that PLC/DGK-derived PA represents a novel downstream component of NO signaling cascade during plant defense. | INTRODUCTION |
|---|
|
|
|---|
One of the second messengers reported to participate in plant defense responses is nitric oxide (NO).2 NO treatments induce plant defense-related transcript accumulation (1, 2), whereas treatments with different inhibitors of NO accumulation compromise the hypersensitive response (HR), a form of programmed cell death induced during plant defense (3). Cryptogein, an elicitor from oomycete Phytophthora cryptogea, triggers NO production that subsequently participates in the mobilization of Ca2+ from internal stores, thereby increasing Ca2+ cytosolic concentrations (4). In animals, NO has been shown to control Ca2+ homeostasis (5). In addition, NO and reactive oxygen species (ROS) have been found to act together triggering apoptosis and executing invasive pathogens (6). In plants, a balanced production of NO and ROS was required for HR (7, 8). Nevertheless, how exactly these two second messengers are related is unknown.
The oxidative burst is a massive production of ROS that can act (i) directly on the pathogens, (ii) indirectly by strengthening the cell wall, and (iii) as a signal activating downstream responses such as the induction of pathogenesis-related (PR) proteins and HR. In plants, there is pharmacological evidence that NADPH oxidase is the main source of ROS required for the induction of HR (9). Genetic experiments have shown that NADPH oxidase is essential for ROS production in the interaction between Arabidopsis and avirulent Pseudomonas syringae pv. tomato but also that the effect on the HR is modest (10). More recently, it was demonstrated that ROS generated by Arabidopsis NADPH oxidase can antagonize salicylic acid-dependent pro-death signals (11). It has been observed that the lipid signaling molecule phosphatidic acid (PA) is involved in the activation of NADPH oxidase in macrophages (12). In plants, PA has been shown to be able to trigger an oxidative burst suggesting a similar activation of NADPH oxidase (13–15). Protein kinase (PDK1) reported to be involved in oxidative burst-mediated signaling, has also been shown to bind PA and to be activated by PA (16, 17).
PA is produced in response to many different stresses including drought, pathogen attack, and oxidative stress (18, 19). It is generated via two distinct phospholipase pathways, either directly by phospholipase D (PLD) or by the sequential action of phospholipase C (PLC) and diacylglycerol (DAG) kinase (DGK). Both pathways have been shown to be involved in the generation of the oxidative burst in several pathosystems (13, 20–22). PLD hydrolyzes structural phospholipids, such as phosphatidylcholine (PC), to PA. PLC hydrolyzes phosphatidylinositol (PI) 4,5-bisphosphate (PIP2) into two different second messengers, DAG and inositol 1,4,5-trisphosphate (IP3). IP3 is described in animals in the signaling of Ca2+ release from internal stores, whereas in plants, DAG is rapidly phosphorylated by DGK, generating PA (23). PA generated via the PLC/DGK-enzymatic pathway occurs in response to pathogen-derived molecules, such as specific elicitors or pathogen-associated molecular pattern (13, 20, 22, 24). A well studied pathogen-associated molecular pattern is xylanase. Recently, a xylanase receptor was identified in tomato (25). Xylanase perception triggers ethylene biosynthesis, electrolyte leakage medium alkalinization, gene expression, and HR (26–29). So far, the intermediate signals have not been well defined. In cultured tomato cells treated with xylanase, both PLD and PLC/DGK is activated (24, 29); in addition, ROS production has been demonstrated (30). We hypothesize a role for NO downstream of xylanase perception and have investigated (i) NO production; (ii) the function of NO in reported PA signaling; and (iii) the function of NO and PA in the induction of ROS, gene expression, and cell death. Our results indicate that xylanase treatment induces NO and that NO is necessary for PA production. Moreover, NO and the subsequent PA generation via the PLC/DGK pathway, are required for xylanase-induced ROS production, gene expression, and cell death. These results provide evidence that xylanase-induced NO activates PLC/DGK signaling during plant defense.
| EXPERIMENTAL PROCEDURES |
|---|
|
|
|---|
-phosphatidic acid, dioctanoyl, C8:0) and PC (didecatanoyl, C10:0) were purchased from Sigma. A stock solution of 10 mM PA or PC was prepared in 1 mM Tris-HCl, pH 8. Cell Suspensions—Suspension-cultured cells (Solanum lycopersicon cv. Money Maker; line Msk8) were grown at 24 °C in the dark at 125 revolutions per min in Murashige-Skoog medium (Duchefa, Haarlem, The Netherlands) supplemented with 5.4 µM naphthalene acetic acid, 1 µM 6-benzyladenine, and vitamins (Duchefa) as described earlier (31).
Treatments—Suspension-cultured cells of 4–5 days old were exposed to different treatments in Petri dishes (for RNA isolation), 2-ml reaction vials (for microscopy and lipid assays), or in microwells (for fluorometric measurements) for different time periods. Inhibitor treatments were performed, incubating the cells 30 min prior to the treatment.
Visualization of NO Using Fluorescence—Endogenous NO was monitored by incubating 100 µl of cells with 1 µM DAF-2DA (or negative control with fluorophore 4-AF DA) for 30 min at 25 °C in the dark. Thereafter, the cells were subjected to different treatments (for the time periods indicated) and mounted on microscope slides. Fluorescence of cells was visualized by fluorescence microscopy with an excitation filter of 485 nm and a barrier filter of 515 nm and bright field microscopy in an Eclipse E 200 (Nikon, Tokyo, Japan) microscope. The production of green fluorescence under these conditions was due to NO. Pictures show general phenomena representative of at least six individual experiments.
Quantification of NO and ROS Production by Fluorometry—Fluorometric measurements were performed in a Fluoroskan Acsent microwell fluorometer (Thermo Electron Company, Vantaa, Finland) using Chroma (Chroma Technology Corp., Rockingham, VT) filters D480-40 and D525-30 for excitation and emission, respectively. Eighty-microliter batches of cultured cells were carefully pipetted into wells of a Greiner 96-well plate containing 0.5 µM DAF-FM-DA or 0.025 µM H2DCF-DA and 20 µl of xylanase in the presence or absence of inhibitors or scavengers, as indicated in Figs. 1 and 4. The microwell plate was immediately transferred to the fluorometer for measurement. Fluorescence of each individual well was measured every 2 min over 20 ms at 25 °C. In between measurements, the temperature was maintained at 25 °C, and cells were shaken at 120 revolutions per min with a 1-cm rotation. All experiments were performed in triplicate.
32Pi Phospholipid Labeling and Analyses—Eighty-five microliters of Msk8 cells were labeled for 3 h with 5 µCi of carrier-free 32PO43- (Amersham Biosciences) prior to treatment with xylanase or SNAP for the time periods and with the concentrations indicated. Control treatments were performed by adding cell-free medium. Incubations were stopped by adding 20 µl of 50% perchloric acid and subsequently frozen in liquid nitrogen. For short-labeling experiments, 85 µl of cell suspension was equilibrated in a 2-ml reaction vial for 2 h. Two minutes prior to the addition of xylanase or SNAP with the concentrations indicated, 20 µl of cell-free medium containing 5 µCi of 32PO43- was added to the cells. Incubations were stopped as mentioned above. The lipids were extracted by adding 3.75 volumes of CHCl3:MeOH:HCl (50:100:1, v/v) and processed as described previously (32). The lipids were separated on Silica-60 thin-layer chromatography (Merck) plates employing EtAc (EtAc/iso-octane/formic acid/H2O 13:2:3:10, v/v) as a mobile phase. When indicated, alkaline solvent (CHCl3:MeOH (25%, w/v), NH4OH:H2O (90:70:4:16, v/v)), heat-activated impregnated thin-layer chromatography plates (1.2%, w/v), potassium oxalate, and 2 mM EDTA in MeOH:H2O (2:3, v/v) were used. Radioactivity was visualized by autoradiograph. The autoradiographs represent general phenomena, representative of at least three individual experiments. Quantification of PA levels was performed by plot analysis using ImageJ (version 1.32j) processing of non-overexposed autoradiographs. PA levels were quantified against the standard structural phospholipid levels (PA/SL) for Fig. 2. For Fig. 3, PA levels were quantified against the total incorporation of 32Pi into phospholipids. The PA level of each sample was subsequently expressed as fold, taking the PA level of the control as 1.
RNA Blot Analysis—Total RNA from tomato cells was isolated using TRIzol as described by the manufacturer (Invitrogen). Fifteen micrograms of total RNA was denatured using glyoxal and subsequently separated on 1.5% agarose gel electrophoresis, and then transferred onto Hybond-XL (Amersham Biosciences). Membranes were hybridized in modified Church solution (0.5 M phosphate buffer, pH 7.2, 7% SDS, and 10 mM EDTA) (33) overnight at 65 °C with radiolabeled fragments of PR1 (34) or PLD
1 (29). Fragments were radiolabeled with the Megaprime DNA labeling system according to the manufacturer's description (Amersham Biosciences) using [
32P]dCTP (Amersham Biosciences). The membranes were washed twice with 2x SSC, 0.1% SDS for 15 min, 1x SSC, 0.1% SDS for 30 min, and 0.2x SSC, 0.1% SDS for 15 min at 65 °C. Hybridization patterns were visualized by autoradiograph. Before rehybridization, blots were stripped by washing the membrane with boiling in 0.5% SDS.
Cell Death—Cell death experiments were performed treating 100 µl of cells with 200 µg/ml xylanase, or 10 µM PA and PC in the presence or absence of inhibitors, as indicated in the figure 6 for 19 h at 25 °C. To quantify cell death, the cells were incubated for 10 min with 0.2 µM CytoxGreen and washed with cell-free medium. The fluorescence was then measured in a Fluoroskan Acsent microwell fluorometer using Chroma filters D480-40 and D525-30 for excitation and emission, respectively. Values are expressed as fold induction with respect to the non-treated cells. Four independent experiments were performed in triplicate. In addition, cells were evaluated by fluorescence microscopy with an excitation filter of 485 nm and a barrier filter of 515 nm and bright field microscopy in an Eclipse E 200 (Nikon, Tokyo, Japan) microscope. Pictures show general phenomena, representative of at least three individual experiments.
| RESULTS |
|---|
|
|
|---|
|
|
2.5-fold as compared with non-treated cells). Xylanase-induced PA levels decreased in a dose-dependent manner when cells were co-incubated with cPTIO. This demonstrates a correlation between the NO level and the PA accumulation during xylanase treatments. Fig. 2B shows increased levels of PA in cells treated with different concentrations of xylanase, as reported earlier (24). This PA accumulation was inhibited when cells were incubated together with 1 mM cPTIO (Fig. 2B). These studies indicate that NO participates in the elicitation of PA generation in xylanase-treated tomato cells. PLC/DGK Activation Is Responsible for the NO-mediated PA Accumulation—Xylanase-dependent PA increase is reported to occur via both PLC/DGK and PLD. To demonstrate which of the two PA sources NO modulates, experiments were performed directed at either source. The main PA source during xylanase treatments is via PLC/DGK (24). PLC hydrolyzes PIP2, generating DAG, which is subsequently phosphorylated by DGK to produce PA. A short radiolabeling strategy (39) was applied to study whether NO mediates PA formation via PLC/DGK. The method is based on the fact that 32Pi is rapidly incorporated into the ATP pool but slowly into structural phospholipids. AT32P can subsequently be used rapidly by DGK to phosphorylate the PLC-derived DAG to 32PA. In contrast, 32PA derived from PLD activity is only detected upon slow labeling of its substrate, a structural phospholipid such as PC. The latter requires long 32Pi labeling times. Consequently, after a short labeling period, any 32PA produced results from DGK and, hence, PLC activity. Accordingly, tomato cells were labeled for 2 min and treated with xylanase for 30 min. Fig. 3 shows that xylanase induces PA production via PLC/DGK activation. To evaluate whether NO mediates PLC/DGK-dependent PA increase, we studied the effect of cPTIO on xylanase-treated cells. NO scavenger cPTIO did inhibit the xylanase-induced PA production from 2.6- to 1.3-fold (folds as compared with PA levels in control cells) (Fig. 3). Specific inhibitors of PLC (U73122 [GenBank] ) or DGK (R59022 [GenBank] ) were used to corroborate that xylanase induces PA formation via PLC/DGK. Inhibition of PLC reduced PA levels from 2.6- to 1.4-fold in xylanase-treated cells. The DGK inhibitor R59022 [GenBank] reduced the xylanase-induced PA levels from 2.6- to 1.7-fold (Fig. 3). PA levels in U73122 [GenBank] -, R59022 [GenBank] -, or cPTIO-treated cells were comparable with the control (Fig. 3). These studies indicate that xylanase-treated cells generate PA via the PLC/DGK pathway and that NO is required in this process.
Experiments were also performed to test whether PLD contributes to the NO-triggered PA formation. PLD has the ability to transfer the phosphatidyl group from its substrate to a primary alcohol, such as 1-butanol (for details, see Ref. 39). cPTIO could not inhibit the xylanase-induced PLD activation (data not shown). However, because the PLD activation during xylanase treatments is low, typically 1.25-fold after 30 min (24), it cannot be discarded that, under our experimental conditions, we were not able to measure a significant effect of NO on PLD activation.
|
Fig. 4A shows the effects of PLC inhibition, DGK inhibition, and NO scavenging on ROS production in xylanase-treated cells. The NO scavenger cPTIO lowered xylanase-triggered ROS production from 100 to 73%. Similar levels of inhibition were found when either the PLC or the DGK inhibitor was used (from 100 to 67 and 63%, respectively). Inhibition of ROS formation is incomplete, which is correlated to the incomplete inhibition of PA formation as shown in Figs. 2 and 3. Hence, these results indicate that xylanase-induced ROS production is, at least partially, dependent on both full NO production and full PLC/DGK activation. If NO acts upstream of PLC/DGK-dependent ROS production, then PLC/DGK inhibitors should not affect xylanase-induced NO levels. NO production in the presence and absence of PLC/DGK inhibitors was measured using the DAF-FM-DA fluorescent probe. The DGK inhibitor did not reduce the xylanase-induced NO production, whereas the PLC inhibitor U73122 [GenBank] slightly reduced the NO levels (Fig. 4B). The NO and ROS levels in control treatments were not affected by the inhibitors (data not shown).
|
1. PLD
1 has been demonstrated to be responsible for xylanase-induced PLD activation (29, 30). Transcript levels were studied by mRNA blot analysis. Fig. 5 shows a xylanase-induced increase of PLD
1 and PR1 transcript levels. Preincubations with NO scavenger cPTIO inhibited this response, indicating that NO is required for the increase of transcript levels. PLC inhibitor U73122
[GenBank]
also inhibits the increase in the mRNA accumulation of PLD
1 and PR1 upon xylanase treatments (Fig. 5). The use of the inhibitors did not alter cell viability (Fig. 6). These data indicate that NO and PLC activity are required for PLD
1 and PR1 transcript accumulations during xylanase treatments. Xylanase induces cell death, which is correlated with the oxidative burst (28). Here we show that xylanase induces ROS production and that this accumulation requires NO and PLC/DGK activation (Fig. 4). Because NO and ROS are involved in the induction of cell death and because xylanase-induced ROS production partially depends on both NO and PA, we studied whether xylanase requires NO and PA to induce cell death. Cells were treated with xylanase in the presence or absence of NO scavenger cPTIO, PLC inhibitor U73122
[GenBank]
, or DGK inhibitor R59022. Cell death was determined 19 h after treatments by measuring the fluorescence of non-cell-permeating DNA-intercalating dye CytoxGreen (44). Cell death is expressed as fold induction with respect to non-treated cells (control, Fig. 6A). Fig. 6B shows a representative picture of xylanase-treated cells. Xylanase induces cell death, which is demonstrated by a 2-fold increase in fluorescence with respect to the control (Fig. 6A). Application of NO scavenger or either PLC or DGK inhibitor diminished the fluorescence to levels slightly above control levels (Fig. 6A). Finally, synthetic, water-soluble PA C8:0 treatment induced cell death to levels similar as obtained with xylanase (Fig. 6). Experiments performed with naturally occurring PA showed similar results (data not shown).
|
|
| DISCUSSION |
|---|
|
|
|---|
NO has been shown to be involved in the plant defense response of a growing list of plant-pathogen interactions (reviewed in Ref. 45). The exact function of NO is currently unknown. NO is likely to play various roles, this in analogy to what is found in animals. At this stage, the source(s) of xylanase-induced NO generation is/are unknown. Surprisingly, neither nitric-oxide synthase inhibitors nor the nitrate reductase inhibitor affect the xylanase-induced NO production, suggesting that these enzymes are not involved in the NO generation in our experimental system. Because several sources for NO production have been described in plants, such as xanthine oxidase, peroxidase, cytochrome P450, and heme proteins (37), genetic evidence will be necessary to assess this aspect. A number of mechanisms by which NO activates PLC/DGK can be envisaged. NO could (i) act directly on PLC or DGK enzymes by nitrosilation or nitration (46–48); (ii) act indirectly, e.g. via a mitogen-activated protein kinase signaling cascade (49–51) or by increasing cytosolic Ca2+ levels (52); (iii) change the redox potential affecting the signaling state of plants (53). At this point, it is not clear which of the above mechanisms are involved in NO-mediated PLC/DGK activation. This will be subject of future studies. In animals, NO modulates PIP2 hydrolysis and the subsequent generation of IP3 negatively (54). NO inhibition of PLC mediated via accumulation of cGMP and activation of G kinase is a widespread regulatory process that involves different types of PLC (54). Our results show, contrary to what is described in animals, that NO activates (via a so far unknown mechanism, see above) the PLC/DGK pathway during plant defense. However, the PLC pathway in plants has been suggested to be different from the "canonical" pathway described for mammalian cells (55). In addition, mammalian cells contain 5 classes of PLC isozymes
,
,
,
and
, whereas Arabidopsis has 7 putative PLC isoforms that are closely related to the animal PLC
(56).
PA is, similar to NO, emerging as a novel second messenger. PA is in animals involved in many processes including the regulation of oxidative stress, cell proliferation and cytoskeleton rearrangement. One of the responses downstream PA reported earlier is the activation of NADPH oxidase in animals (12). In plant-pathogen interactions, several reports indicate that the oxidative burst is due to an activation of membrane-bound NADPH oxidase. Correspondingly, the induction of oxidative stress in plants occurs downstream PA (13–15, 21). Our results suggest that PLC/DGK-generated PA is involved in the rapid accumulation of ROS in xylanase-treated cells, and that NO is required in this process (Fig. 4). The oxidative burst in plant-pathogen interactions mediated by specific elicitors occurs in two phases. The first phase shows a rapid (5 min onward), transient (60 min) and low ROS production whereas the second phase shows a prolonged (3–6 h) and massive ROS production (9). A biphasic ROS generation was observed and associated with the activation of PLC and PLD in rice cells induced by N-acetylchitooligosaccharide elicitor. The activation of both enzymes was shown for the first phase of ROS generation, whereas for the second phase only the activation of PLD was evident (20). Recognition of P. syringae AvrRpm1 or AvrRpt2 in Arabidopsis induced a biphasic accumulation of PA. The first wave was attributed to the PLC/DGK pathway, the second to PLD; both phospholipase pathways acted upstream of ROS formation (22). PA accumulated rapidly via PLC/DGK in tobacco cells expressing the tomato Cf-4 resistance protein treated with Cladosporium fulvum Avr4 protein. PLC activity was required for the rapid ROS accumulation (13). Our results show that, NO-dependent, PLC/DGK-generated PA is involved in the induction of ROS production during the first peak of the oxidative burst in xylanase-treated cells. PLD activation during xylanase treatments could contribute to activation of NADPH oxidase, as suggested in rice cells, via an NO-independent pathway. A second phase of oxidative burst has so far not been studied following xylanase treatments.
Various PA target proteins in animals have been identified over the years, e.g. PA has been shown to activate a protein kinase, protein phosphatases, a lipid kinase, a phospholipase and a transcription factor (57, 58). Also in plants a number of PA targets have been identified suggesting PA is involved in many processes (59). PA has been shown to bind a protein kinase in Arabidopsis (PDK1) and to activate protein kinase AGC2-1 in a PDK-dependent manner (16, 60). PDK1 is specifically activated by PLD-generated PA in cell suspensions treated with xylanase (61). AGC2-1 is identical to OXI1, a protein kinase implicated in oxidative burst-mediated signaling in Arabidopsis (17). Studies show that PA activates a calcium-dependent protein kinase (CDPK) and a wound-related mitogen-activated protein kinase cascade (62, 63). NO activates a mitogen-activated protein kinase and a CDPK during adventitious root formation (50, 64). PLD
1-derived PA interacts with ABI1 phosphatase 2C and regulates abscisic acid (ABA) signaling during stomatal closure in Arabidopsis (65, 66). NO was shown to act upstream of ABI1 in ABA-induced stomatal closure (67). Future experiments will be performed to elucidate which of the PA downstream targets are related to NO-triggered cascade during xylanase treatments.
Xylanase is known to induce an increase of mRNA levels of, among others, PR1 and PLD
1. PLD
1 has been demonstrated to be responsible for xylanase-induced PLD activation (29, 30). Fig. 5 shows a xylanase-induced increase of PLD
1 and PR1 transcript levels. Preincubations with either NO scavenger cPTIO or the PLC inhibitor U73122
[GenBank]
inhibited this response (Fig. 5). The use of the inhibitors did not alter cell viability (Fig. 6). These data indicate that NO and PLC activity are required for PLD
1 and PR1 transcript accumulations during xylanase treatments.
ROS and NO have been shown to be required for cell death during plant defense (7, 8, 68). We showed that NO and PLC/DGK-derived PA are required for xylanase-induced cell death. All of the xylanase-induced responses evaluated in this study (PLC/DGK-derived PA, ROS generation, induction of gene expression, and cell death) could be blocked by depletion of endogenous NO. This indicates NO is required for these xylanase-induced responses. This puts forward the question whether NO is sufficient for these xylanase-induced responses. We performed a series of experiments with NO donors to investigate this. Exogenously applied SNAP induces PA formation in a dose-dependent manner (supplemental Fig. S1A), but the concentrations required are high. One mM SNAP induces a 2–3-fold increase in PA formation via PLC/DGK within minutes (supplemental Fig. S1B), as was shown for xylanase previously (24). Inhibition of SNAP-induced PA formation was shown upon preincubation with inhibitors of PLC and DGK (supplemental Fig. S1C). Accordingly, PLC and the DGK inhibitors reduced SNAP-induced cell death (data not shown). Hence, it appears as if NO is also sufficient to induce PA formation via PLC/DGK. However, the concentration of SNAP that is required for the induction of significant levels of PA is high, which makes confirmation of the direct effect of NO uncertain. Scavenging the SNAP-released NO by cPTIO is required to unequivocally show that exogenously applied NO activates PA formation. The concentration of cPTIO required for the effective scavenging of NO released by 1 mM SNAP is 10–20 mM (50, 69–74), which is toxic to tomato cell suspensions. Hence, such scavenging experiments cannot be performed. Two opposite explanations should therefore be made. On the one hand, xylanase-induced NO might be produced locally upon perception of xylanase by the receptor located at the plasma membrane. Given the short half-life of NO, this will result in a high local concentration but a more moderate global concentration. To mimic the local NO concentration that occurs upon xylanase, high doses of SNAP must be applied to mimic xylanase-induced NO. On the other hand, such high concentration of SNAP exceeds the global concentration as induced by xylanase, which might very well induce other pleiotropic or indirect effects. We can therefore not exclude that PA production induced by SNAP-released NO does not reflect the actual events following xylanase treatment. Hence, the results shown in supplemental Fig. S1 suggest that NO solely induces the formation of PA, although the concentration of SNAP required could induce pleiotropic effects.
All together, our results unravel a signaling pathway that occurs after pathogen perception. Briefly, xylanase is perceived by the cell, triggering a rapid NO production (Fig. 1). NO then induces a PLC/DGK-dependent PA formation (Figs. 2 and 3). Finally, PA induces ROS production probably via the activation of the NADPH oxidase (13–15). Another source of PA in xylanase-treated cells occurs via PLD activation. SNAP treatments did not result in a detectable increase of PLD activity (see supplemental Fig. S2), and cPTIO could not inhibit the xylanase-induced PLD activation (data not shown). Thus, PLD activation is proposed as a NO-independent pathway. Genetic approaches are required to unequivocally demonstrate the initial order of events following xylanase perception. NO-null mutants should be used to prove its suggested function. Unfortunately, the complexity of possible NO sources make straightforward genetic approaches to this problem in tomato unfeasible (37). Our data, but also data by many other authors, suggest that PA is upstream of ROS production. A model about PA and ROS signaling in (a)biotic stress was recently proposed (18). We cannot, however, exclude that ROS might also act upstream of PA or even upstream of NO. There are reports that show that (i) H2O2 induces PA formation in rice cells (75), (ii) H2O2 is required for NO production in ABA-treated Arabidopsis guard cells (42), and (iii) H2O2 triggers NO production in mung bean (76) and tobacco cells (68). NADPH oxidase-null mutants in tomato, as used by Torres et al. (10, 11) in Arabidopsis, might show whether ROS act upstream of NO and PA formation during xylanase treatments. Another interesting issue results from the fact that NO and ROS are both oxidizing agents. We can envisage functional overlap, but as was shown for HR in Arabidopsis (7), it might also be that both reactive species are required either in concert or in independent signaling pathways with or without feedback regulation, as was suggested earlier (77). It will be a challenge to elucidate exactly how NO, PA, and ROS are interrelated in stress signaling.
Another compound that is related to NO, PA, and ROS is Ca2+. PLC activation also results in the formation of IP3 that, either directly or indirectly via its metabolized form IP6, may result in the release of Ca2+ from internal stores (78, 79). Inhibition of PLC does also slightly affect NO production (Fig. 4B), suggesting a possible feedback mediated by either PA or IP3. Inhibition of DGK (Fig. 4B) or reduction of PLD-produced PA does not affect NO production (see supplemental Fig. S2), suggesting IP3 and Ca2+ to be responsible for this putative feedback. Concordantly, it was shown that NO is required for the mobilization of Ca2+ from internal stores (4, 52). Downstream, Ca2+ might affect PLC, DGK, PLD (23), and NADPH oxidase (12), therewith constituting a feedback toward PA generation via PLC/DGK regulation and PLD. In animals, PLC activity has been shown to be part of the NO-dependent machinery that controls Ca2+ homeostasis via IP3 (5). Given the incomplete inhibition levels observed, genetic evidence will be required to unequivocally show whether and how this feedback occurs.
| FOOTNOTES |
|---|
The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1 and S2. ![]()
1 To whom correspondence should be addressed: Instituto de Investigaciones Biológicas, Universidad Nacional de Mar del Plata, CC 1245, 7600 Mar del Plata, Argentina. Tel.: 54-223-4753030; Fax: 54-223-4753150; E-mail: amlaxalt{at}mdp.edu.ar.
2 The abbreviations used are: NO, nitric oxide; PA, phosphatidic acid; PLC, phospholipase C; PLD, phospholipase D; DGK, diacylglycerol (DAG) kinase; HR, hypersensitive response; PR, pathogenesis-related; NADPH, nicotinamide adenine dinucleotide phosphate; ROS, reactive oxygen species; SNAP, S-nitroso-N-acetylpenicillamine; cPTIO, 2-(4-carboxyphenylalanine)4,4,5,5 tetramethylimidazoline-1-oxyl-3-oxide potassium; IP3, inositol 1,4,5-trisphosphate; PIP2, phosphatidylinositol 4,5-bisphosphate. ![]()
| ACKNOWLEDGMENTS |
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. Kasprowicz, A. Szuba, D. Volkmann, F. Baluska, and P. Wojtaszek Nitric oxide modulates dynamic actin cytoskeleton and vesicle trafficking in a cell type-specific manner in root apices J. Exp. Bot., April 1, 2009; 60(6): 1605 - 1617. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-p. Han and Y.-j. Yuan Lipidomic analysis reveals activation of phospholipid signaling in mechanotransduction of Taxus cuspidata cells in response to shear stress FASEB J, February 1, 2009; 23(2): 623 - 630. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Wu and J.-Y. Wu Extracellular ATP-induced NO production and its dependence on membrane Ca2+ flux in Salvia miltiorrhiza hairy roots J. Exp. Bot., October 1, 2008; 59(14): 4007 - 4016. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Lanteri, A. M. Laxalt, and L. Lamattina Nitric Oxide Triggers Phosphatidic Acid Accumulation via Phospholipase D during Auxin-Induced Adventitious Root Formation in Cucumber Plant Physiology, May 1, 2008; 147(1): 188 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Foresi, A. M. Laxalt, C. V. Tonon, C. A. Casalongue, and L. Lamattina Extracellular ATP Induces Nitric Oxide Production in Tomato Cell Suspensions Plant Physiology, November 1, 2007; 145(3): 589 - 592. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |